The medium and long-term debt of pharmaceutical firm Unimed listed on Tunisia stock exchange grew by 448% year to year in S1, 2019 to reach TND20.8 million.

The firm explains that during the period under review, it borrowed TND4.8 million from banks for its expansion project.

According to Moroccan media citing Charfeddine Ridha (photo), UNIMED’s managing director, an TND80 million-investment plan is announced for the expansion of the firms’ laboratories.

Despite the growth of its debt, Unimed’s turnover rose by 124% year on year to reach TND31.1 million thanks to its sales on local and foreign markets that quarter.

Chamberline MOKO